In a similar context, patients diagnosed with MDS harboring WT1 mutation (n = 20) showed a significantly higher incidence of relapse post-HSCT compared to patients with wild-type WT1 (n = 116; 39) [36]. This evidence concerns the gene WT1 and myelodysplastic syndrome.